{"nct_id":"NCT01218126","title":"Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-centre, Dose Ranging Study to Evaluate the Efficacy and Safety of Losmapimod Tablets Administered Twice Daily Compared With Placebo for 24 Weeks in Adult Subjects With Chronic Obstructive Pulmonary Disease (COPD).","status":"COMPLETED","status_verified_date":"2018-01","start_date":"2010-11-04","start_date_type":"ACTUAL","primary_completion_date":"2011-12-21","primary_completion_date_type":"ACTUAL","completion_date":"2011-12-21","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}